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　Smith-Magenis syndrome (SMS) is a contiguous gene syndrome caused by an 
interstitial deletion of chromosome 17p11.2. The clinical SMS spectrums include short 
stature, brachydactyly, developmental delay, dysmorphic features, mental retardation, 
hyperactivity, self-injury, seizures, and sleep abnormalities (especially, reduced REM 
sleep). Here we attempted to define the minimum common deletion at 17p11.2 in 8 
Japanese patients with SMS using molecular cytogenetic approaches, including a 
prophase fluorescence in situ hybridization (FISH) ordering system and a stretched 
DNA fiber FISH. Our precise deletion mapping constructed by FISH revealed that one 
patient with SMS showed a much smaller deletion at 17p11.2 as compared with the 
other 7 patients with SMS.  LLGL1 and FLII, previously mapped within the SMS 
critical deletion, were mutually nested, and retained on both chromosomes 17 in two 
patients. ZNF179, a RING finger protein family gene, on the SMS critical region was 
deleted on one of the two homologues 17p11.2 in 6 out of 8 patients with SMS in the 
present study.  ZNF179 is a "neuronal gene" mapped on the SMS critical deletion and 
seems to be one of the candidates most likely to be affected with an impairment of the 
CNS in SMS patients. However, ZNF179 was retained on both 17p11.2 in two SMS 
patients exhibiting clinical findings characteristic of SMS, suggesting that ZNF179 
might not be associated with the neurobehavioral impairments in SMS.  Furthermore, 
DNA fragments from the region at 17p11.2 contained highly repetitive sequences, 
probably including the low-copy repeats (LCRs) associated with the deletion/duplication 
mechanism through non-allelic homologous recombination in the patients with SMS.
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INTRODUCTION
　Smith-Magenis syndrome (SMS) is a con-
tiguous gene syndrome caused by an intersti-
tial deletion of chromosome 17p11.21),2).  There 
is no deviation in the parent origin of a deleted 
chromosome, and no participation of genomic 
imprinting. From Caucasian statistics, 1/25,000 
people are affected with SMS.  On the other 
hand, there seems to be a lesser frequency of 
this disease in Japan, because only a limited 
number of Japanese SMS patients have been 
reported so far3).  The spectrum of clinical 
findings of SMS include short stature, brachy-
dactyly, developmental delay, dysmorphic fea-
tures, mental retardation, hyperactivity, self-
injury, seizures, and sleep abnormalities (espe-
cially reduced REM sleep)4), 5).
　The genomic materials involved in the 
chromosomal deletion at 17p11.2 are recog-
nized to be physically different among SMS 
patients6),7).  Recently, Chen et al. identified 3 
copies of a low-copy repeat (LCR) located 
within and flanking the SMS common deletion, 
and suggested that homologous recombination 
of a flanking repeat cluster is a mechanism of 
this microdeletion syndrome8). In particular, 
recombination between repeated sequences at 
various regions of the human genome are 
known to give rise to DNA rearrangements 
associated with  many genetic disorders in-
cluding SMS 9). 
　Chromosomal abnormalities have provided 
important clue in the mapping of a number of 
genes, including some of particular interest to 
pediatricians. Positional cloning strategy based 
on "deletion mapping" has been applied to the 
task of gene identifications affecting human 
diseases. An important example is the gene for 
Duchenne  muscular  dystrophy  (DMD  ; MIM
 310200), which was discovered through study-
ing a patient with concomitant muscular 
dystrophy,    McLeod   syndrome  (DMD  ;  MIM
 308350),  and chronic granulomatous diseases 
due to a X chromosome deletion that had 
removed a set of contiguous genes. This 
evidence indicates that the minimal common 
deletions in patients with SMS might harbor 
genes affected with characteristic neurobehav-
ioral abnormalities.
　Here we attempted to define the minimum 
common deletion at 17p11.2 in 8 Japanese 
patients with SMS, using molecular cytoge-
netic approaches including a prophase fluores-
cence in situ hybridization (FISH) ordering 
system10) and the stretched DNA fiber FISH11).  
Our precise deletion mapping constructed by 
FISH revealed that one patient with SMS 
showed a much smaller deletion at 17p11.2 as 
compared with the other 7 SMS patients.  
LLGL1 and FLII, previously mapped within 
the SMS critical deletion, were mutually 
nested and retained on both chromosomes 17 
in this patient. Furthermore, DNA fragments 
from the region at 17p11.2 contained highly 
repetitive    sequences    associated    with    the
deletion/duplication mechanism through non-
allelic homologous recombination.
SUBJECTS AND METHODS
Patients  
　All of 8 SMS patients examined here were 
Japanese,    and    exhibited    clinical    findings
characteristic of SMS. Details of the clinical 
manifestations were obtained from only 4 
patients (Pt 1, 2, 5 and 6) as listed in the Table 
1. We could not obtain any information about 
whether these patients showed an absence of 
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REM sleep, although this phenotype had been 
reported previously12). Chromosome analyses 
by standard or high-resolution G-banding 
methods showed del(17)(p11.2p11.2) in all 
patients.  Preliminary cytogenetic and clinical 
findings in 4 patients (Pt 1, 2, 5 and 6) were 
previously reported by Kondo et al. 3).  Epstein-
Barr (EB) virus-transformed lymphoblastoid 
cell lines (LCLs) were established from the 
peripheral lymphocytes of these patients 
according to the method described by 
Fukushima et al13). Before the study, appropri-
ate informed consents were obtained from the 
parents of each patient. 
Mapping of del(17)(p11.2) in 8 patients 
with SMS 
　EB virus-transformed LCLs of each patient 
were cultured in RPMI1640 supplemented 
with 10% fetal bovine serum, and metaphase 
cells from each patient were prepared as 
described 14).  Normal metaphase chromosomes 
as the control were prepared from peripheral 
lymphocytes derived from healthy volunteers.
　FISH to metaphase chromosomes was 
carried out as previously described10) with 24 
cosmid markers mapped on 17p11-12 (CI 17-
498, 502, 505, 532, 536, 596, 603, 608, 631, 638, 
681, 688, 693, 695, 705, 712, 724, 729, 802, 814, 
825, 827, 828, and 832)15). These cosmids were 
chosen from a cytogenetic map of chromosome 
 Table 1. Clinical Findings in 4 Japanese Patients with SMS
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Craniofacial
　Brachycephaly
　Flat midface
　upward slant of palpebral fissures
　Strabismus
　Unusual mouth shape
　Prognathism
Extremities
　Short hands
　Brachydactyly
　Scoliosis
Growth, development 
　Short stature
　Mental retardation
　Hyperactivity
　Self-mutilation
　Seizure
　Sleep disturbance
Others
　Cardiac defect
　Genital anomalies
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17, which was constructed by high-resolution 
FISH with 324 newly isolated cosmids15).  In 
addition, cosmids containing each of three 
genes, FLII, LLGL1, and ZNF179, were used 
as probes, since these three genes had been 
mapped within the SMS critical deletion at 
17p11.216)-18). The 70E2 and 62F2 cosmids, 
kindly provided by Dr. James R. Lupski, 
contained 3' and 5' DNA fragments of the 
human FLII gene, respectively16). A cosmid 
clone, designated as cAR5 for the human 
LLGL1 gene, was isolated by Koyama et al.17),  
and a clone cosBFP containing the human 
ZNF179 gene was isolated by Orimo et al.18). 
　For the precise mapping and ordering of 
FLII, LLGL1, and ZNF179 by FISH, slides of 
prophase chromosomes and stretched DNA 
fibers were prepared10),11).  DNA probes were 
labeled with biotin (BIO)-16-dUTP or digoxi-
genin (DIG)-11-dUTP (Roch, Germany) by 
nicktranslation.  Labeled probes (final concen-
tration 25 ng/ml) were added to a hybridization 
solution consisting of 50% formamide, 10% 
dextran sulfate, and 2xSSC.  Sonicated salmon 
sperm DNA (2μg/μl), Escherichia coli tRNA 
(2μg/μl), and Cot-1 DNA (125 ng/ml), were 
added to eliminate background-noise due to 
repetitive sequences such as Alue and L1. A 
hybridization reaction was carried out at 37℃ 
overnight. After the slides were washed in the 
appropriate condition, a BIO- or DIG-labeled 
probe was detected with avidin-FITC (Boehrin-
ger - Mannheim) or anti - DIG Rhodamine 
(Boehringer - Mannheim), respectively. The 
chromosome slides were then counterstrained 
with DAPI (1μg/ml), and mounted in antifade 
solution containing 1% DABCO19). Then, 
multicolor fluorescent signals were simultane-
ously observed using a Nikon FXA fluorescent 
microscope equipped with a dual band-pass 
filter.  The order and orientation of the signals 
on band 17p11.2 were determined by a pair-
wise comparison along the longitudinal axis of 
the chromatids of elongated prophase chromo-
somes. Further, to examine the  precise  ar-
rangement  of  overlapping cosmids, FISH 
signals on stretched DNA fibers were observed 
as described11), 20).
Analysis of the FLII and LLGL1 genes 
　Since FLII and LLGL1 were localized in 
close proximity to each other in our prophase 
FISH, we performed stretched DNA fiber 
FISH to determine the precise arrangement of 
70E2 and cAR5 on a DNA fiber. Cosmids 70E2 
and cAR5 contained 3’genomic fragments of 
FLII and LLGL1, respectively.  
　In addition, after 70E2 and cAR5 were 
double-digested with EcoRI and Not I, their 
DNA fragments were  electrophoresed in  0.8% 
agarose-gel,  and   we    then    constructed   EcoRI /
Not I restriction maps of 70E2 and cAR5. As 
shown in Fig.2, 4 DNA fragments from both 
cosmids were completely identical. We sub-
cloned  these  DNA  fragmentsinto pBluscript(+) 
and determined the sequences of each clone by 
a Pharmacia ALF express DNA sequencer 
(Pharmacia Biotech Inc.), according to the 
manufacturer's instruction.
RESULTS
Construction of a Deletion Map in Pa-
tients with 17p(11.2-11.2) by FISH
　A chromosomal deletion at 17p11.2 was 
detected in all patients with SMS examined by 
FISH, although the sizes of the chromosome 
materials    involved    in    the    deletion   were
physically different.  Seven patients (Pt 2-7) 
showed a relatively large deletion involved in 
at  least  11 cosmids (cCI17-832, -695, -593/603, 
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-638, -825, -631, -681, -693, -827, -536, -502, 
c70E2, and cAR5). On the other hand, Pt 1 
showed a hemizyogous deletion harboring only 
3 cosmids (-695, -593/603, and -638).  In 
addition, FISH signals generated by cCI17-
688, -712, -729, and -828 showed a repetitive 
pattern at 17p11.2-12 along the longitudinal 
axis of chromosome region 17, strongly 
suggesting that these 4 cosmids contained 
17p11.2-region-specific repetitive sequences.  
　The ZNF179 gene, previously localized 
within the critical deletion for SMS at 
17p11.221), was retained on both homologous 
chromosomes 17p in Pt 1 and Pt 8.  These 
results taken together showed that the most 
smallest 17p11.2 deletion of overlapping, 
critical to SMS, among our 8 patients was the 
deletion involved in Pt 1, as shown in Fig.1.
Physical Ordering of FLII, LLGL1, and 
ZNF179 by FISH
　Our prophase FISH ordering system showed 
the order of three cosmids, FLII, cCI17-502, 
and ZNF179 from the centromere to the 
telomere (Fig.1).  However, FISH signals for 
FLII overlapped signals for LLGL1, even on 
elongated prophase chromosomes, in all the 
cells examined. Our observation strongly 
suggested that both genes might be localized 
less than 100kb apart, based on our previous 
　Fig. 1.  Mapping of deletions at 17p11.2 in 8 Japanese patients (P1-8) with SMS by FISH.
FISH to metaphase and interphase chromosomes was carried out with cosmids (CI17 series) 
previously mapped on chromosome bands 17p11-12. The numbers indicate that of each cosmid in cCI-
17 cosmids. CI17-596 and -608 were overlapped, and CI17-681 had a Not1 restriction site.  Each 
opened rectangle indicates a hemizygous deletion of the cosmids. Closed rectangles indicate a 
retention of the cosmids on both homologous chromosomes 17p. Shaded rectangles indicate a 
retention of the cosmids containing repetitive sequences. Among the 8 patients, Pt1 showed least 
deletions, involving only 3 cosmids. FLII, LLGL1, and ZNF179 were previously reported to be 
localized within the SMS critical deletion, although all of the three were retained in Pt1.
Characterization in Patients with SMS
－116－
　Fig. 3.  Restriction map of genomic DNA fragments digested with EcoRI and Not I 
The bar indicates 4kb. Four DNA fragments each from the c70E2 and cAR5 cosmids were completely 
identical. These DNA fragments were subcloned into pBluscript(+) and their sequences were 
analyzed by a DNA autosequencer. The sequences of each fragment were completely identical (data 
not shown). This data, together with the stretched DNA fiber FISH, clearly indicated that FLII and 
LLGL1are mutually "nested genes". 
　Fig. 2.  (Top) Stretched DNA fiber FISH to determine the arrangement of the FLII and LLGL1 
genes
Cosmid clones, 70E2 (☆) and 62F2 (＊), contained 5’- and 3’-FLII genomic fragments, respectively, 
and were detected as FITC signals. Rhodamine-labeled cosmid cAR5 (◇) contained LLGL1. The 
yellow signals (arrow-head) were detected as a psudo-color generated by overlapping of the green 
signals for 70E2, and the red signals for cAR5, unambiguously indicating that FLII and LLGL1were 
nested. 
(Bottom) Schematic representation of the same image. Cosmids of 70E2, 62F2 and cAR5 on a DNA 
fiber.
study21). Indeed, as shown in Fig.2, more 
precise mapping of these two genes by 
stretched DNA fiber FISH clearly showed that 
FISH signals of c70E2, a cosmid containing the 
3' DNA fragment of FLII, overlapped signal 
generated by cAR5 containing the 3' DNA 
fragment of LLGL1.  These results, together 
with the results from the restriction maps 
(Fig.3), showed that these two genes were 
nested. Indeed, sequences of DNA fragments 
from c70E2 and cAR5 were completely 
identical (data not shown).
Chromosomal Deletions and Clinical 
Findings in Japanese Patients with SMS
　In order to define the possible relationship of 
the difference between the clinical findings and 
the physical size of the17p11.2 deletion in 
patients with SMS, we examined the clinical 
findings in 4 patients (Pt 1, 2, 5 and 6) with 
respect to their deletions. As listed in the Table 
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1, these 4 patients showed a similar clinical 
spectrum for SMS, except for "seizures" and 
"sleep disturbance".  These two phenotypes, 
associated with an impairment of the central 
nerve system (CNS), were observed only in Pt 
2, who exhibited a hemizygous deletion of 
cCI17-832 localized on the most distal part of 
the SMS critical deletion, as shown in Fig.1
DISCUSSION
　SMS is a multiple congenital anoma-
lies/mental retardation syndrome associated 
with an interstitial deletion of chromosome 17 
involving band 17p11.2. It is hypothesized to 
be a contiguous gene syndrome in which the 
phenotype arises from the haplo-insufficiency 
of multiple and functionally unrelated genes in 
close physical proximity, although the true 
molecular basis of this syndrome has not yet 
been clarified. Therefore, in the present study, 
we carried out molecular cytogenetic charac-
terization of chromosomal deletions at 17p11.2 
in 8 Japanese patients with SMS.
　Previously, two different genes, FLII and 
LLGL1, were mapped within the SMS critical 
deletion, and the haploinsufficiency of these 
genes might be affected with SMS16),17). FLII is 
the human orthologue of Drosophila mela-
nogaster flightless-1 gene, fliI, in which 
mutations result in the loss of flight ability, and 
when severe, is lethal due to its incomplete 
cellularization    with    subsequent    abnormal
gastrulation. Chen et al. reported that FLII is 
mapped within the SMS critical region, and 
that this gene was hemizygously deleted in 12 
SMS patients. They also suggested that the 
haploinsufficiency of this gene might be 
associated with the pathogenesis of SMS. On 
the other hand, LLGL1 is the orthologue of the 
murine Llgl, which was originally isolated as a 
homologue of a Drosophila tumor suppressor 
gene l(2)gl (lethal(2) giant larvae).  Koyama et 
al. isolated LLGL1, and mapped it on 17p11.2, 
which is a critical region of SMS.  In the 
present study, we clearly delineated two 
genomic DNA fragments containing parts of 
LLGL1 and FLII at the same position along a 
DNA fiber, unambiguously indicating that the 
3' end of FLII physically overlapped the 3'end 
of the LLGL1 gene (Fig.2). It is noteworthy 
that LLGL1 and FLII were mutually "nested 
genes", as previously reported in human red 
and green color pigment genes on chromosome 
Xq2822).  Furthermore, LLGL1 and FLII were 
detected on both homologous chromosomes 
17p11.2 in one SMS patient (Pt 1), who showed 
representative clinical phenotypes for SMS. 
Taken together, haplo-insufficiency at LLGL1 
and FLII might not be critical in the spectrum 
of clinical findings such as short stature, 
brachydactyly, developmental delay, dysmorphic 
features, sleep disturbances, and behavior 
problems, all of which were possessed by Pt 1. 
　We previously mapped the human brain 
finger protein gene, ZNF179, of the RING 
finger protein family, on the critical region of 
SMS at 17p11.2.  Indeed, as shown in Fig.1, 
this gene was deleted on one of the two 
homologues 17p11.2 in 6 (Pt 2-7) out of 8 
patients with SMS in the present study. 
ZNF179 is a "neuronal gene"18) and seems to be 
the candidate gene most likely to be affected 
with an impairment of the CNS in SMS 
patients. However,  two patients (P t1, 8) har-
boring ZNF179 on both 17p also showed 
clinical symptoms characteristic of SMS 
(Fig.1).  These findings strongly suggest that 
ZNF179 might not be associated with the 
manifestations of the SMS complex phenotypes 
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associated with an impairment of the CNS.
　Furthermore, in order to define the possible 
relationship between the difference in clinical 
findings and the region involved in the 17p11.2 
deletion in patients with SMS, we examined 
the clinical findings in 4 patients (Pt 1, 2, 5 and 
6) with respect to a deletion at 17p11.2.  As 
listed in Table 1, these 4 patients showed 
almost the same spectrum of clinical manifesta-
tions  characteristic   of   SMS,   except for  
"seizures" and "sleep disturbance", which were 
observed only in Pt 2.  Particularly, Pt 2 
showed a hemizygous deletion of cCI17-832, 
whereas this cosmid was retained on both 
homologous chromosomes 17p11.2 in the other 
3 patients without both manifestations. These 
results strongly suggest that the genes 
relevant to "seizures" and "sleep disturbance" in 
SMS are likely to lie on the distal region within 
the critical deletion for SMS, surrounding 
cCI17-832.
　In order to identify the critical deletion 
involved in SMS, we tried to minimize the 
common deletion among our 8 patients. We 
first performed high-resolution FISH with a 
number of cosmid markers mapped on 17p11.2-
12.  As shown in Fig.1, 7 out of the 8 patients 
examined showed relatively large deletions 
involving at least 11 cosmids, whereas one 
patient (Pt1) showed a hemizygous deletion 
involving only 3 cosmids. These results 
strongly suggest that the most minimal 
deletion responsible for SMS lies within the 
deletion detected in Pt1, because the clinical 
manifestations of this patient showed almost 
all the clinical findings characteristic for SMS. 
Further studies are necessary to evaluate the 
genes associated with neurobehavioral abnor-
malities characteristic for SMS, within the 
common and minimum deletions of patients 
with SMS, to understand the pathogenesis of 
SMS. Almost all of the genes with known or 
unknown functions have been identified and 
localized on the human genome in the post-
sequence era. Now that information concern-
ing the human genome is more advanced, 
nonrandom and recurrent genomic alterations, 
specific to certain diseases, can provide the key 
exploring novel therapeutic approaches for 
incurable diseases and understanding the most 
appropriate management for "personalized 
medicine".
　The stability of the human genome is 
influenced to a greater extent by low-copy 
repeats (LCRs). LCRs are region-specific DNA 
blocks usually 10-400kb in size with a >95-
97% similarity. Through the process of non-
allelic homologous recombination, LCRs may 
lead    to    DNA    rearrangement:     deletions,
duplications, inversions and translocations. 
Recently, Lupski et al. detected LCRs within or 
flanking the SMS critical region and suggested 
that the SMS deletion was caused by the 
mechanism of NAHR 8). Indeed, our FISH 
showed that 4 cosmids contained repetitive 
sequences, probably including LCRs, within or 
flanking the region of the SMS critical 
deletion, supporting the idea that dele-
tion/duplication at 17p11.2 is the result of the 
reciprocal procedure of an unequal crossing-
over via LCRs, that was recently named SMS-
REP.8), 9).
　We thank the SMS patients and their 
families for the participation in our study, and 
Drs. Yoshimitsu Fukushima and Ikuko Kondo 
for the generous gift of the EBV-transformed 
LCLs. We also thank Honorary Professor 
Tatsuo Abe and his colleagues for their 
encouragement.
Kimura, Hayasaka, Inazawa
－119－
REFERENCES
1. Smith ACM, McGavran L, Robinson J, 
Waldstein G, Macfarlane J, Zonona J, et al.: 
Interstitial deletion of (17) (p11.2p11.2): report 
of six additional patients with a new chromo-
some deletion syndrome. Am J Med Genet 
1986; 24: 421-432
2. Fischer H, Oswald HP, Duba HC, Doczy L, 
Simma B, Utermann G, et al.: Constitutional 
interstitial deletion of 17(p11.2)(Smith-Mage-
nis syndrome): a clinically recognizable micro-
deletion syndrome: report of two cases and 
review of the literature. Clin Pediatr 1993; 205: 
162-166 
3. Kondo I, Matsuura S, Kuwajima K, Tokashiki 
M, Izumikawa Y, Naritomi K, et al.: Diagnotic 
hand anomalies in Smith-Magenis syndome: 
four new patients with del(17)(p11.2p11.2). Am 
J Med Genet 1991; 41: 225-229
4. Lockwood D, Hecht F, Dowman C, Hecht BK, 
Rizkallah TH, Goodwin TM, et al.: Chromo-
some subband 17p11.2 deletion: a minute 
deletion syndrome. J Med Genet 1988; 25: 732-
737 
5. Colley AF, Leversha MA, Voullaire LE, Rogers 
JG: Five cases demonstrating the distinctive 
behavioural features of chromosome deletion 
17 (p11.2p11.2) (Smith-Magenis syndrome). J 
Pediatr Child Health 1990; 26:17-21
6. Zori RT, Lupski JR, Heju Z, Greenberg F, 
Killian JM, Gray BA, et al.: Clinical, cytogene-
tic and molecular evidence for an infant with 
Smith-Magenis syndrome born from a mother 
having a mosaic 17p11.2p12 deletion. Am J 
Med Genet 1993; 47: 504-511 
7. Greenberg F, Guzzetta V, Montes de Oca-Luna 
R, Magenis RE, Smith ACM, Richter SF, et al.: 
Molecular analysis of the Smith-Magenis 
syndrome: a possible contiguous gene syn-
drome associated with del(17)(p11.2). Am J 
Hum Genet 1991; 49: 1207-1218
8. Chen KS, Manian P, Koeuth T, Potocki L, Zhao 
Q, Chinault AC, et al.: Homologous recombina-
tion of a flanking repeat gene cluster is a 
mechanism for a common contiguous gene 
deletion syndrome. Nature Genet 1997; 17: 154-
163
9. Potocki  L, Chen KS, Park SS, Osterholm DE, 
Withers MA, Kimonis V, et al.: Molecular 
mechanism for duplication 17p11.2-the homolo-
gous recombination reciprocal of the Smith-
Magenis microdeletion. Nature Genet 2000; 24: 
84-87 
10. Inazawa J, Ariyama T, Tokino T, Tanigami A, 
Nakamura Y, Abe T: High resolution ordering 
of DNA markers by multi-color fluorescent in 
situ hybridization of prophase chromosomes. 
Cytogenet Cell Genet 1994; 65: 130-135 
11. Parra I, Windle B: High resolution visual 
mapping of stretched DNA by fluorescent 
hybridization. Nature Genet 1993; 5: 17-21 
12. Tandan R, Taylor R, Adesina A, Sharma K, 
Fries T, Pendlebury W: Benign autosomal 
dominant syndrome of neuronal Charcot-Marie-
Tooth disease,  ptosis,  parkinsonism,  and de-
mentia. Neurology 1990; 40: 773-779
13. Fukushima Y, Ohashi H, Wakui K, Nishida T, 
Oh-ishi T: A rapid method for starting a 
culture for the establishment of Epstein-Barr 
virus-transformed human lymphoblastoid cell 
lines. Jpn J Hum Genet 1992; 37: 149-150
14. Kimura T, Arakawa Y, Inoue S, Fukushima Y, 
Kondo I, Koyama K, et al.: The brain finger 
protein gene (ZNF179), a member of the RING 
finger family, maps within the Smith-Magenis 
syndrome region at 17p11.2. Am J Med Genet 
1997 ; 69 : 320-324 
15. Inazawa J, Saito H, Ariyama T, Abe T, 
Nakamura    Y:    High-resolution    cytogenetic
　mapping of 342 new cosmid markers including 
43 RFLP markers on human chromosome 17 
by fluorescence in situ hybridization. Genomics 
1993; 17: 153-162 
Characterization in Patients with SMS
－120－
16. Chen KS, Gunaratne PH, Hoheisel JD, Young 
IG, Miklos GLG, Greenberg F, et al.: The 
human homologue of the Drosophila mela-
nogaster flightless-I gene (fliI) maps within the 
Smith-Magenis microdeletion critical region in 
17p11.2. Am J Hum Genet 1995; 56: 175-182 
17. Koyama K, Fukushima Y, Inazawa J, 
Takahashi N, Nakamura Y: The human 
homologue of the murine mgl-1 gene maps 
within the Smith-Magenis region in 17p11.2. 
Cytogenet Cell Genet 1996; 72: 78-82 
18. Matsuda Y, Inoue S, Seki N, Hosoi T, Orimo A, 
Muramatsu M, et al.: Chromosome mapping of 
human (ZNF179), mouse and rat genes for 
brain finger protein (bfp), a member of the 
RING finger family. Genomics 1996; 33: 325-
327
19. Kimura T: The counterstrain and fluores-
cence prevention of FISH method. In: Abe T, 
Inazawa J eds. Rinsyo FISH protocol. Tokyo; 
Syujunsya, 1997: 72-74
20. Ariyama T, Kimura T, Yamakawa K, 
Nakamura Y, Abe T, Inazawa J: Precise 
ordering of 26 cosmid markers on chromosome 
region 3p-23->p21.3 by two-color FISH on 
human prophase chromosomes and stretched 
DNAs. Cytogenet Cell Genet 1995; 70: 129-133
21. Kimura T, Arakawa Y, Inoue S, Fukushima Y, 
Kondo I, Koyama K, et al.: The brain finger 
protein gene (ZNF179), a member of the RING 
finger family, maps within the Smith-Magenis 
syndrome region at 17p11.2. Am J Med Genet 
1997; 69: 320-324 
22. Hanna MC, Platts JT, Kirkness EF: 
Identification of a gene within the tandem 
array of red and green color pigment genes. 
Genomics 1997; 43: 384-386
Kimura, Hayasaka, Inazawa
